Although higher visceral fat levels [26] and sex hormone estrogen [27] in women could potentially contribute to MetS risk, the sex heterogeneity should be further examined in more large population-based cohort studies worldwide. The gene discussed is PLXNA3; the disease is metabolic syndrome.